Table 1 Correlation between VDR expression and clinicopathological characteristics in PAAD patients
Characteristics | VDR | P.overall | |
|---|---|---|---|
|  | High (n = 66) | Low (n = 21) |  |
Gender | Â | Â | 0.129 |
 Female | 23 (34.8%) | 3 (14.3%) |  |
 Male | 43 (65.2%) | 18 (85.7%) | 0.650 |
Age(years) | 56.3 | 55.1 | Â |
 Tumor location |  |  | 0.880 |
 Head | 41 (62.1%) | 12 (57.1%) |  |
 Neck/Body/Tail | 25 (37.9%) | 9 (42.9%) |  |
Differeation | Â | Â | 0.420 |
 High | 20 (30.3%) | 4 (19.0%) |  |
 Low | 9 (13.6%) | 5 (23.8%) |  |
 Moderate | 37 (56.1%) | 12 (57.1%) |  |
T stage | Â | Â | 0.024* |
 1–2 | 9 (13.6%) | 8 (38.1%) |  |
 3–4 | 57 (86.4%) | 13 (61.9%) |  |
N stage | Â | Â | 0.336 |
 0 | 50 (75.8%) | 13 (61.9%) |  |
 1 | 13 (19.7%) | 6 (28.6%) |  |
M stage | Â | Â | 0.352 |
 0 | 62 (93.9%) | 18 (85.7%) |  |
 1 | 4 (6.06%) | 3 (14.3%) |  |